4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow eravacycline: new trials by email Literature Review of eravacycline trials Research Report on eravacycline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and PK Study of IV Eravacycline Eravacycline (TP-434) - Bacterial Infections | Phase 1 | Completed | Tetraphase Pharmaceuticals, Inc | 19 | 2018-12-20 | 2021-12-03 |
| A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects eravacycline - End Stage Renal Disease | Phase 1 | Completed | Tetraphase Pharmaceuticals, Inc | 12 | 2013-12-01 | 2021-12-17 |
| A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects eravacycline - Impaired Hepatic Function | Phase 1 | Completed | Tetraphase Pharmaceuticals, Inc | 24 | 2013-10-01 | 2021-12-17 |
| Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women TP-434 (Eravacycline) reconstituted and administered via an IV infusion - Normal Drug Tolerance | Phase 1 | Completed | Tetraphase Pharmaceuticals, Inc | 20 | 2012-11-01 | 2021-12-17 |
Bacterial Infections (1) · Kidney Failure, Chronic (1)
Tetraphase Pharmaceuticals, Inc (4)
United States (3)
Chris Galloway, MD (1) · Patrick T Horn, MD, PhD (1) · Thomas Marbury, MD (1) · William Smith, MD (1)